Researcher
Stephane Steurbaut
- Keywords:Pharmacy and pharmacology, Medicine, General and logistic services
- Disciplines:Cardiology, Clinical pharmacy, Pharmacotherapy, Pharmaceutical care
Affiliations
- Clinical Pharmacology and Clinical Pharmacy (Research group)
Member
From1 Sep 2011 → Today - Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Jan 2021 → Today - Pharmaceutical and Pharmacological Sciences (Department)
Member
From8 Apr 2019 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Pharmaceutical Chemistry, Drug Analysis and Drug Information (Department)
Member
From1 Oct 2012 → 31 Dec 2013 - Pharmaceutical Chemistry, Drug Analysis and Drug Information (Department)
Member
From1 Oct 2010 → 30 Nov 2012 - Pharmacology (Department)
Member
From1 Oct 2010 → 30 Sep 2012 - Clinical Pharmacology and Pharmacotherapy (Department)
Member
From1 Jan 2008 → 30 Jun 2019 - Studiebegeleidingscentrum (Administrative office)
Member
From12 Feb 2001 → 31 Dec 2001 - Pharmaceutical Biotechnology and Molecular Biology (Department)
Member
From1 Jan 1997 → 31 Dec 2006
Publications
1 - 10 of 49
- Medication Review: What’s in a Name and What Is It about?(2024)
Authors: Anneleen Robberechts, Maja Brumer, Victoria Garcia-Cardenas, Niurka M. Dupotey, Stephane Steurbaut, Guido R Y De Meyer, Hans De Loof
- The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation(2024)
Authors: Maxim Grymonprez, Mirko Petrovic, Tine L M De Backer, Stephane Steurbaut, Lies Lahousse
Pages: 135-148 - Development and partial validation of Be-CLIPSS(2024)
Authors: Silke Verheyen, Stephane Steurbaut, Pieter-Jan Cortoos, Stephanie C M Wuyts
Pages: 80-89 - Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation(2024)
Authors: Maxim Grymonprez, Mirko Petrovic, Tine L M De Backer, Stephane Steurbaut, Lies Lahousse
Pages: 55-65 - Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants(2023)
Authors: Maxim Grymonprez, Mirko Petrovic, Tine L M De Backer, Stephane Steurbaut, Lies Lahousse
- Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs(2023)
Authors: Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine L M De Backer, Lies Lahousse
Pages: 781-791 - Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism(2023)
Authors: Els Mehuys, Bruno Lapauw, Guy T'Sjoen, Thierry Christiaens, A De Sutter, Stephane Steurbaut, Inge Van Tongelen, Koen Boussery
Pages: 918-926 - Patient experiences and opinions on medication review(2023)
Authors: Anneleen Robberechts, Laura Van Loon L, Stephane Steurbaut, Guido R Y De Meyer, Hans De Loof
Pages: 650-658 - Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance(2023)
Authors: Souad Moudallel, Celien Helene P Van den Eynde, Josef Malý, Silas Rydant, Stephane Steurbaut
Pages: 1143-1153 - Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019(2023)
Authors: Maxim Grymonprez, Tine L M De Backer, Andreas Capiau, Delphine Vauterin, Els Mehuys, Koen Boussery, Stephane Steurbaut, Lies Lahousse
Pages: 1360-1373